The ABSA Road to Leadership will feature 2 independent courses—the 5th Annual Leadership Institute (April 22-25) and the Certification Review Course (April 26-27). Both courses will be offered at the Embassy Suites Lake Buena Vista Florida. Discounts will be offered for registering for both courses. For more information and registration, please visit the Official Event Read More »
Calendar of Events
April 20, 2012
Princeton Biosecurity Seminar: Roles and Responsibilities of the Research and Security Communities
Addressing Biosecurity: Roles and Responsibilities of the Research and Security Communities Ed You, Supervisory Special Agent, FBI’s Weapons of Mass Destruction Directorate, Biological Countermeasures Unit Sponsored by the MacArthur Foundation. The seminar will be held on Friday, April 20 from 12:30 pm to 2:00 pm in the Carl Icahn Laboratory, Room 280. Lunch will be Read More »
April 19, 2012
Book Release: Innovation, Dual Use, and Security
The James Martin Center for Nonproliferation Studies Invites you to a book release presentation on: Innovation, Dual Use, and Security: Managing the Risks of Emerging Biological and Chemical Technologies Edited by: Jonathan B. Tucker, PhD Hosted by: Leonard S. Spector Deputy Director, James Martin Center for Nonproliferation Studies With remarks from contributors: Kirk Bansak The Read More »
NIH Public Meeting on the Draft Supplementary Risk Assessment for the Boston University NEIDL
The National Institutes of Health will host a public meeting on Thursday, April 19, 2012, from 6:30-9:30 p.m. at Roxbury Community College, Main Stage, 1234 Columbus Avenue, Boston, MA 02120. The purpose of the meeting is to solicit public comments regarding the Draft Supplementary Risk Assessment for the National Emerging Infectious Diseases Laboratories. Comments provided Read More »
NIH Public Meeting on the Draft Supplementary Risk Assessment for the Boston University NEIDL
The National Institutes of Health (NIH) will hold a public meeting on Thursday, April 19. The purpose of the meeting is to solicit public comments regarding the Draft Supplementary Risk Assessment for the National Emerging Infectious Diseases Laboratories. Comments provided during the meeting, as well as those received during the public comment period, will be Read More »
